ClinicalTrials.govpublic full text
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
hypertension, insulin resistance, metabolic syndrome, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891252
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.